Estrogen receptor polymorphisms and incident dementia: The prospective 3C study
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Genetic variation in the estrogen receptor (ESR) may be associated with the incidence of Alzheimer's disease (AD), but this association could be modified by genetic and environmental factors. Methods: The association between five ESR α (ESR1) and β (ESR2) polymorphisms with 7‐year dementia incidence was examined among 6959 older men and women from the Three City Study using multivariate‐adjusted Cox regression models with delayed entry. Gender, the apolipoprotein E (APOE) ε4 allele, and hormone treatment were considered as potential effect modifiers of this association. Results: Among women, the CC genotype of ESR1 rs2234693 was specifically associated with a small increased risk of AD (adjusted hazard ratio [HR]: 1.54, 95% confidence interval [CI]: 1.03–2.28, P = .03). However, women with this genotype had a substantially increased risk of AD associated with the APOE ε4 allele (adjusted HR: 3.24, 95% CI: 1.81–5.79 for women rs2234693 CC; compared with HR: 1.87, 95% CI: 1.37–2.56 for all women). There was also evidence of a nominally significant interaction between the ESR1 and ESR2 polymorphisms on the risk of all dementias (P = .04). Hormone treatment did not modify these associations, and there were no significant associations in men. Conclusions: Although there was only weak support for a gender‐specific association between the common ESR1 rs2234693 polymorphism and AD, this polymorphism may act as an effect modifier, modifying the association between an ESR2 polymorphism and dementia, as well as the risk of AD associated with the APOE ε4 allele.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 1×
“Recent genome-wide association studies (GWAS) have identified a few candidate genes for Alzheimer’s disease (AD) [1,2]; however, together these genes only explain a small amount of the underlying genetic component of the disease [3].”
BackgroundSelf-citationSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 4×
“Large scale meta-analyses which combine results from multiple studies, such as the Alzheimer Research Forum [17] (http://www.alzgene.org) are therefore important for the identification of other genetic risk factors, in particular those with strong a priori biologically hypotheses indicating their involvement in the di…”
BackgroundInfluentialGenetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452 · cited 2×
“It is likely that several other genetic factors are involved, but they may be missed in individual studies or GWASwith stringent statistical thresholds and consequently low power to detect associations [3].”
BackgroundGenome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733 · cited 1×
“Finally, it is possible that these gender differences can be partly explained by sex dimorphism in brain morphology, neurochemistry, and neuronal wiring (see for review [41]).”
Background(2003) · Neuroepidemiology · doi:10.1159/000072920 · Cited by 672 · cited 1×
“: 133499614565; Fax: 133499614579. anne.ryan@inserm.fr nt matter 2014 The Alzheimer’s Association.”
Cited by
Age, APOE and sex: triad of risk of Alzheimer’s disease.
Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.012 · Cited by 627
Risk factors for Alzheimer’s disease
A. Armstrong, R. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.85929 · Cited by 606
Estrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
Impact of a premature menopause on cognitive function in later life
Ryan, J., Scali, J., Carrière, I., Amieva, H., Rouaud, O., Berr, C., Ritchie, K., & Ancelin, M. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12828 · Cited by 209
Self-citationSex Differences in Alzheimer’s Disease: Insights From the Multiomics Landscape
Guo, L., Zhong, M. B., Zhang, L., Zhang, B., & Cai, D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.968 · Cited by 164
Metadata
- Authors
- Ryan, J., Carrière, I., Carcaillon, L., Dartigues, J., Auriacombe, S., Rouaud, O., Berr, C., Ritchie, K., Scarabin, P., & Ancelin, M.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2013-03-14
- Volume
- 10
- Issue
- 1
- Pages
- 27-35
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2068024033
- Cited by
- 36
- References
- 6
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estrogen receptor polymorphisms and incident dementia: The prospective 3C study. https://app.cochat.ai/papers/10.1016/j.jalz.2012.12.008
- The paper
- Ryan, J., Carrière, I., Carcaillon, L., Dartigues, J., Auriacombe, S., Rouaud, O., Berr, C., Ritchie, K., Scarabin, P., & Ancelin, M. (2014). Estrogen receptor polymorphisms and incident dementia: The prospective 3C study. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2012.12.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.